The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prospective observational comparison of outcomes in African American and Caucasian patients receiving second-line treatment with pemetrexed for advanced non-small cell lung cancer (NSCLC).
E. J. Pennella
Employment or Leadership Position - Lilly
G. Pohl
Employment or Leadership Position - Lilly
A. C. Girvan
Employment or Leadership Position - Lilly
K. Winfree
Employment or Leadership Position - Lilly
B. Martinez
Employment or Leadership Position - Lilly
C. K. Obasaju
Employment or Leadership Position - Lilly
M. S. Walker
Research Funding - Lilly
E. J. Stepanski
Research Funding - Lilly
L. S. Schwartzberg
Research Funding - Lilly
A. A. Adjei
Research Funding - Lilly